cevimeline hydrochloride
NDC 43386-999, cevimeline hydrochloride, capsule, from Lupin Pharmaceuticals,Inc..
- Product NDC
- 43386-999
- Status
- Listed
- Labeler
- Lupin Pharmaceuticals,Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204746
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43386-999 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CEVIMELINE HYDROCHLORIDE30 mg/1
Pharmacologic classes
Cholinergic Muscarinic Agonists [MoA]; Cholinergic Receptor Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/0fbcf1a7-5b8b-42fb-b764-4b529e7d1a99
Use it
Look up 43386-999 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43386-999 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43386-999. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.